BNTC - benitec.com Profit before interest, taxes and amortization
The EBITDA in monetary terms visualizes the dynamics of the high-tech ecosystem of Benitec Biopharma Inc. (BNTC), which utilizes proprietary defective gene suppression. Meanwhile, the 0.00 indicator expresses the state of the operating profit metric. Benitec Biopharma Inc. (BNTC) revenues are based on investments and grants, while business development is currently limited by the clinical trial stage and strict FDA oversight.
Benitec Biopharma (BNTC) - metric breakdowns and financial figures
- current price and projected stock value:
- market capitalization statistics:
- book capitalization data:
- business debt structure and liquidity details:
- earnings and multiples data:
BNTC - Net Profit|Projected Future Earnings Benitec Biopharma Inc.|BNTC - Price to Earnings Ratio|Future Price to Earnings Multiple benitec.com|BNTC - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Benitec Biopharma|BNTC - Operating profit EBITDA|Net earnings per share (EPS TTM) Benitec Biopharma|BNTC - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months benitec.com|BNTC - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Benitec Biopharma Inc.
Analysis of all company metrics:Benitec Biopharma Inc.
The scale of Benitec Biopharma Inc. (BNTC) operations in the gene therapy sector determines the trend dynamics of its operating profit before interest and taxes. This indicator measures the net cash inflow from core activities prior to debt servicing, allowing for an assessment of the efficiency of its unique RNA platforms and the resilience of the company's capitalization to external market shocks, excluding tax distortions.
Competitors of Benitec Biopharma Inc. (BNTC)
Company profit before taxes, interest and amortization TEM (Tempus)|Qiagen N.V. - Operating profit EBITDA|Profit before interest, taxes and amortization ionispharma.com|RGEN: Operating profit EBITDA|Operating profit before deduction of amortization Avidity Biosciences Inc|Operating profit before deduction of amortization CRSP|WGS: Income before deduction of interest, taxes and amortization|Operating profit EBITDA RARE|Profit before payment of interest, taxes and amortization BEAM (beamtx.com)|Operating profit EBITDA SRPT (Sarepta)|Operating income before deduction of amortization Twist Bioscience Inc (TWST)|TXG - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Intellia Corp|Stoke Therapeutics (STOK) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization BLFS (biolifesolutions.com)|WVE (Wave Life Sciences Ltd.) - Operating profit EBITDA|MAZE: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SION|Operating profit EBITDA Prime Medicine Bio (PRME)|Profit before payment of interest, taxes and amortization Taysha Gene Therapies TSHA|Income before deduction of interest, taxes and amortization QURE|MGTX - Profit before payment of interest, taxes and amortization|REGENXBIO Inc (RGNX) - Operating profit before deduction of amortization|SLDB: Operating profit EBITDA|Ocugen Pharma (OCGN) - Operating profit EBITDA|Operating profit before deduction of amortization PACB|DSGN: Income before deduction of interest, taxes and amortization|Operating profit EBITDA RCKT|Operating income before deduction of amortization 4DMT|Profit before payment of interest, taxes and amortization Lexeo Therapeutics, Inc. LXEO|KRRO: Operating profit before amortization|Editas Medicine, Inc. - Operating profit EBITDA|silence-therapeutics.com (SLN) - Operating profit before deduction of amortization|PRQR (proqr.com) - Operating profit before deduction of amortization|CDXS - Operating income before deduction of amortization|SGMO (Sangamo) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NAUT|Profit before payment of interest, taxes and amortization Metagenomi, Inc. (MGX)|precisionbiosciences.com - Operating profit before amortization|Generation Bio - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization BOLD (Boundless Bio Inc.)|Exicure Corp - Operating profit EBITDA|Imunon, Inc. (IMNN) - Operating profit before deduction of amortization|PHIO: Operating profit EBITDA|Operating profit before amortization MBIO|Profit before payment of interest, taxes and amortization TransCode Therapeutics Inc.|Operating profit before amortization BNGO (Bionano)|Operating profit EBITDA APDN|Operating profit EBITDA bluebird bio, Inc (BLUE)|Operating profit EBITDA IPA (ImmunoPrecise Antibodies Ltd.)|omegatherapeutics.com - Profit before payment of interest, taxes and amortization|Singular Genomics - Operating profit EBITDA|Profit before interest, taxes and amortization Regulus Therapeutics, Inc.|Syros (SYRS) - Profit before payment of interest, taxes and amortization|Operating profit before amortization TBIO|TCON (TRACON Pharmaceuticals) - Operating profit EBITDA|unitybiotechnology.com (UBX) - Operating income before deduction of amortization
